AstraZeneca Plc (AZN):企業の財務・戦略的SWOT分析

◆英語タイトル:AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH3904FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:114
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

AstraZeneca Plc (AZN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AstraZeneca Plc (AstraZeneca) is a biopharmaceutical company that discovers, produces and commercializes a wide range of prescription drugs. It focuses on therapy areas of respiratory; cardiovascular and renal and metabolic diseases; and cancer, besides autoimmune, infection and neurological diseases. The company’s product portfolio includes biologics, prescription pharmaceuticals and vaccines. AstraZeneca sells its products through wholly-owned local marketing companies, distributors and local representative offices. The company markets its products to primary care and specialty care physicians. The company operates in Europe, the Americas, Asia, Africa and Australasia. AstraZeneca is headquartered in Cambridge, Cambridgeshire, the UK.

AstraZeneca Plc Key Recent Developments

Mar 21,2021: Statement on the passing of José Baselga
Mar 08,2021: The global medical industry fund jointly created by CICC Capital and AstraZeneca completed the first round of fundraising
Mar 04,2021: AstraZeneca: Designation of EU home member state for EU securities regulation purposes
Mar 04,2021: JCR Pharmaceuticals: Notice of construction of new plant for COVID-19 vaccine solution
Feb 23,2021: Lung Cancer Research Foundation announces new research collaboration with AstraZeneca

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
AstraZeneca Plc – Key Facts
AstraZeneca Plc – Key Employees
AstraZeneca Plc – Key Employee Biographies
AstraZeneca Plc – Major Products and Services
AstraZeneca Plc – History
AstraZeneca Plc – Company Statement
AstraZeneca Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
AstraZeneca Plc – Business Description
Business Segment: Biopharmaceuticals
Overview
Performance
Business Segment: Externalisation Revenue
Overview
Performance
Geographical Segment: Asia, Africa & Australasia
Target Markets
Performance
Geographical Segment: Continental Europe
Target Markets
Performance
Geographical Segment: The Americas
Target Markets
Performance
Geographical Segment: UK
Performance
R&D Overview
AstraZeneca Plc – Corporate Strategy
AstraZeneca Plc – SWOT Analysis
SWOT Analysis – Overview
AstraZeneca Plc – Strengths
AstraZeneca Plc – Weaknesses
AstraZeneca Plc – Opportunities
AstraZeneca Plc – Threats
AstraZeneca Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
AstraZeneca Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 21, 2021: Statement on the passing of José Baselga
Mar 08, 2021: The global medical industry fund jointly created by CICC Capital and AstraZeneca completed the first round of fundraising
Mar 04, 2021: AstraZeneca: Designation of EU home member state for EU securities regulation purposes
Mar 04, 2021: JCR Pharmaceuticals: Notice of construction of new plant for COVID-19 vaccine solution
Feb 23, 2021: Lung Cancer Research Foundation announces new research collaboration with AstraZeneca
Feb 11, 2021: AstraZeneca: Full-year 2020 results
Feb 05, 2021: Oxford to initiate trial of different Covid-19 vaccines
Feb 04, 2021: World’s first Covid-19 vaccine alternating dose study launches in Nottingham
Jan 28, 2021: CELLINK announces third year extension of collaboration with a global biopharmaceutical company for drug discovery
Jan 27, 2021: BenevolentAI and AstraZeneca achieve collaboration milestone with novel AI-generated chronic kidney disease target
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
AstraZeneca Plc, Key Facts
AstraZeneca Plc, Key Employees
AstraZeneca Plc, Key Employee Biographies
AstraZeneca Plc, Major Products and Services
AstraZeneca Plc, History
AstraZeneca Plc, Subsidiaries
AstraZeneca Plc, Joint Venture
AstraZeneca Plc, Key Competitors
AstraZeneca Plc, Ratios based on current share price
AstraZeneca Plc, Annual Ratios
AstraZeneca Plc, Annual Ratios (Cont...1)
AstraZeneca Plc, Annual Ratios (Cont...2)
AstraZeneca Plc, Interim Ratios
AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AstraZeneca Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
AstraZeneca Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[AstraZeneca Plc (AZN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Avista Corporation (AVA)-エネルギー分野:企業M&A・提携分析
    Summary Avista Corporation (Avista) is an electric and natural gas utility. The company produces, transmits, and distributes electricity; and supplies natural gas on retail and wholesale basis. It sources electricity from its facilities and contracted hydroelectric, thermal and wind generation facil …
  • Nationwide Mutual Insurance Company:企業の戦略・SWOT・財務情報
    Nationwide Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Nationwide Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • TaiwanJ Pharmaceuticals Co Ltd (6549):製薬・医療:M&Aディール及び事業提携情報
    Summary TaiwanJ Pharmaceuticals Co Ltd (TaiwanJ) is a pharmaceutical company that develops and commercialize small molecules for unmet medical needs such as chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It develops TLR4, a transmembrane protein that provides key medi …
  • Hensel Phelps Construction Co:企業の戦略的SWOT分析
    Hensel Phelps Construction Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Fauji Fertilizer Bin Qasim Limited (FFBL)-エネルギー分野:企業M&A・提携分析
    Summary Fauji Fertilizer Bin Qasim Limited (FFBL) is a chemical manufacturing company that manufactures, supplies and markets di ammonium phosphate (DAP) and granular urea. In addition, the company undertakes production and marketing of ammonia and other nitrogenous fertilizers for agricultural appl …
  • Fluxys SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Fluxys SA (Fluxys), a subsidiary of Publigas, is an independent natural gas infrastructure group. It carries out natural gas transmission, gas storage and terminalling of liquefied natural gas (LNG). Besides, the group conducts natural gas trading activities in the spot market. The company s …
  • QPS Austria GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary QPS Austria GmbH (QPS), a subsidiary of QPS Holdings LLC, is a contract research organization (CRO) which provides preclinical and clinical research services. The company offers in vivo services which include generating, characterizing and maintaining transgenic disease models and use them f …
  • Bakkavor Group Limited:企業の戦略・SWOT・財務情報
    Bakkavor Group Limited - Strategy, SWOT and Corporate Finance Report Summary Bakkavor Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Winbond Electronics Corporation (2344):企業の財務・戦略的SWOT分析
    Winbond Electronics Corporation (2344) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • TIBCO Software, Inc.:企業の戦略・SWOT・財務情報
    TIBCO Software, Inc. - Strategy, SWOT and Corporate Finance Report Summary TIBCO Software, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • China Non-ferrous Metal Industry’s Foreign Engineering and Construction Co Ltd:企業の戦略・SWOT・財務分析
    China Non-ferrous Metal Industry's Foreign Engineering and Construction Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Non-ferrous Metal Industry's Foreign Engineering and Construction Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data …
  • GDS Holdings Ltd (GDS):企業の財務・戦略的SWOT分析
    GDS Holdings Ltd (GDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Midatech Pharma Plc (MTPH)-医療機器分野:企業M&A・提携分析
    Summary Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercialize oncology and other therapeutic products. The company’s products include gelclair, oravig, soltamox, zuplenz, ferralet 90 and aquoral. It conducts research and development programs in areas of oncology, …
  • Mitsui E&S Holdings Co., Ltd:企業の戦略・SWOT・財務分析
    Mitsui E&S Holdings Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Mitsui E&S Holdings Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • SRS Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary SRS Medical Systems Inc (SRS Medical) is a medical device company that designs, manufactures and markets diagnostics and disposable products. The company offers spanner, test systems, urodynamic systems, uroflows, uroscan bladder ultrasound systems and disposables. Its disposables products c …
  • Immunicom Inc:医療機器:M&Aディール及び事業提携情報
    Summary Immunicom Inc (Immunicom) is a specialty biotechnology company that develops non-pharmaceutical therapies for oncology and autoimmune diseases. The company offers immune inhibitors that play a key role in protecting tumors from the body’s natural immune mechanisms. It proprietary Immunophere …
  • Scope Metals Group Ltd:企業の戦略・SWOT・財務情報
    Scope Metals Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Scope Metals Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Infosys Ltd (INFY):企業の財務・戦略的SWOT分析
    Infosys Ltd (INFY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Bill & Melinda Gates Foundation:企業のM&A・事業提携・投資動向
    Bill & Melinda Gates Foundation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bill & Melinda Gates Foundation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • Bharti Infratel Ltd:企業の戦略・SWOT・財務情報
    Bharti Infratel Ltd - Strategy, SWOT and Corporate Finance Report Summary Bharti Infratel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆